Restoration of Glucokinase Expression in the Liver Normalizes Postprandial Glucose Disposal in Mice With Hepatic Deficiency of PDK1

  1. Yasuo Okamoto1,
  2. Wataru Ogawa1,
  3. Akihiko Nishizawa1,
  4. Hiroshi Inoue1,
  5. Kiyoshi Teshigawara1,
  6. Shinichi Kinoshita1,
  7. Yasushi Matsuki2,
  8. Eijiro Watanabe2,
  9. Ryuji Hiramatsu2,
  10. Hiroshi Sakaue1,
  11. Tetsuo Noda3 and
  12. Masato Kasuga1
  1. 1Department of Clinical Molecular Medicine, Division of Diabetes and Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe, Japan
  2. 2Genomics Science Laboratories, Dainippon Sumitomo Pharmaceuticals, Takarazuka, Japan
  3. 3Department of Cell Biology, Japanese Foundation for Cancer Research (JFCR), Cancer Institute, Tokyo, Japan
  1. Address correspondence and reprint requests to Wataru Ogawa, Department of Clinical Molecular Medicine, Division of Diabetes and Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe, Japan 657-0011. E-mail: ogawa{at}med.kobe-u.ac.jp

Abstract

Phosphoinositide-dependent kinase-1 (PDK1) is implicated in the metabolic effects of insulin as a key mediator of phosphoinositide 3-kinase–dependent signaling. Here we show that mice with liver-specific PDK1 deficiency manifest various defects in the metabolic actions of insulin in the liver as well as a type 2 diabetes–like phenotype characterized by marked hyperinsulinemia and postprandial hyperglycemia. The hepatic abundance of glucokinase, an important determinant of glucose flux and glucose-evoked signaling in hepatocytes, was substantially reduced in these mice. Restoration of hepatic glucokinase expression, with the use of an adenoviral vector, induced insulin-like effects in the liver and almost completely normalized the fasting hyperinsulinemia and postprandial hyperglycemia in these animals. These results indicate that, if the hepatic abundance of glucokinase is maintained, ingested glucose is normally disposed of even in the absence of acute activation of proximal insulin signaling, such as the activation of Akt, in the liver.

Footnotes

  • Published ahead of print at http://diabetes.diabetesjournals.org on 31 January 2007. DOI: 10.2337/db06-1322.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted January 17, 2007.
    • Received September 19, 2006.
« Previous | Next Article »Table of Contents